Enhancing Innovations in Emerging Technologies for Advanced Manufacturing of Complex Biologic Products (R01)

CBER seeks to support the application of novel technologies for advanced manufacturing of complex biologic products, and innovative analytical approaches to improve product manufacturing and quality...more


NIH Director's Pioneer Award (DP1 - Clinical Trial Optional)
National Institutes of Health
The NIH Directors Pioneer Award supports individual scientists of exceptional creativity who propose highly innovative and potentially transformative approaches to major challenges in the biomedical...more

Tribal Behavioral Health Grant Program (Short Title: Native Connections)
National Institutes of Health
The Substance Abuse and Mental Health Services Administration (SAMHSA), Centers for Mental Health Services (CMHS) and Substance Use Prevention (CSAP), are accepting applications for fiscal year (FY)...more

FY18 Announcement of Availability of Funds for Phase I Replicating Programs (Tier 1) Effective in the Promotion of Healthy Adolescence and the Reduction of Teenage Pregnancy and Associated Risk Behaviors
Office of the Assistant Secretary for Health
The purpose of this funding opportunity announcement (FOA) is to replicate and scale up programs that include the protective factors shown to be effective in the prevention of risk behaviors,...more

FY18 Announcement of the Availability of Funds for Phase I New and Innovative Strategies (Tier 2) to Prevent Teenage Pregnancy and Promote Healthy Adolescence
Office of the Assistant Secretary for Health
The purpose of this funding opportunity announcement is to develop and test new and innovative strategies to prevent teen pregnancy, promote healthy adolescence and address youth sexual risk...more

Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional)
National Institutes of Health
The purpose of this Funding Opportunity Announcement (FOA) is to promote research that transforms understanding of HIV transmission, the HIV care continuum, and HIV comorbidities using Big Data...more

Targeted In Vivo Delivery of Gene Therapeutics for HIV Cure (R01 Clinical Trial Not Allowed)
National Institutes of Health
This Funding Opportunity Announcement (FOA) will support research on the development and validation of innovative strategies to deliver anti-HIV gene therapies efficiently to specific target cells in...more

FY 18 Announcement of Availability of Funds for a Clinical Training and Technical Assistance Project to Support the Title X Family Planning Program
Office of the Assistant Secretary for Health
The Office of Population Affairs (OPA) provides funding for grants and contracts to support training for personnel working in Title X-funded services projects pursuant to section 1003 of the Public...more

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
National Institutes of Health
This FOA provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to warrant...more

Limited Competition: Interaction of HIV Infection and Alcohol Abuse on Central Nervous System Morbidity (U01 Clinical Trial Not Allowed)
National Institutes of Health
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications to evaluate the cumulative and progressive effects on brain structure and cognitive/behavioral function of combined...more